Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry

References

• Balbus JM, Maynard AD, Colvin VL, Castranova V, Daston GP, Denison RA, 2007. Meeting report: hazard assessment for nanoparticles–report from an interdisciplinary workshop. Environ Health Perspect 115:1654–1659.
   PubMed Web of Science ®Google Scholar
• Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA, 2008. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol 5:14.
   PubMed Web of Science ®Google Scholar
• Brain J. 2009. Biologic responses to nanomaterials depend on exposure, clearance, and material characteristics. Nanotoxicology 3:7.
   Google Scholar
• Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, 2010. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 28:1300–1303.
   PubMed Web of Science ®Google Scholar
• Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH. 2010. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5:e8668.
   PubMed Web of Science ®Google Scholar
• Deloid GM, Sulahian TH, Imrich A, Kobzik L. 2009. Heterogeneity in macrophage phagocytosis of Staphylococcus aureus strains: high-throughput scanning cytometry-based analysis. PLoS One 4:e6209.
   Google Scholar
• Demokritou P, Buchel R, Molina RM, Deloid GM, Brain JD, Pratsinis SE. 2010. Development and characterization of a Versatile Engineered Nanomaterial Generation System (VENGES) suitable for toxicological studies. Inhal Toxicol 22(Suppl 2):107–116.
   PubMedGoogle Scholar
• Derjaguin BV. 1941. Theory of the stability of strongly charged lyophobic sols and of the adhesion of strongly charged particlces in solutions of electrolytes. Acta Physicochim 14:30.
   Google Scholar
• Elzey S. 2009. Agglomeration, isolation and dissolution of commercially manufactured silver nanoparticles in aqueous environments. J Nanopart Res 12:14.
   Google Scholar
• Fadeel B. 2010. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 8:9.
   Google Scholar
• Fischer HC, Chan WC. 2007. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565–571.
   PubMed Web of Science ®Google Scholar
• George S. 2011. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano 5:13.
   PubMed Web of Science ®Google Scholar
• Haynes WM. 2011. CRC Handbook of Chemistry and Physics. 92nd edition. Boulder, CO: CRC Press.
   Google Scholar
• Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, 2010. ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol 7:36.
   PubMed Web of Science ®Google Scholar
• Ji Z, Jin X, George S, Xia T, Meng H, Wang X, 2010. Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. Environ Sci Technol 44:7309–7314.
   PubMed Web of Science ®Google Scholar
• Jiang J. 2008. Does nanoparticle activity depend upon size and crystal phase. Nanotoxicology 2:10.
   Google Scholar
• Jiang J. 2009. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:13.
   Google Scholar
• Jones CF, Grainger DW. 2009. In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev 61:438–456.
   PubMed Web of Science ®Google Scholar
• Krewski D, Acosta D Jr, Andersen M, Anderson H, Bailar JC 3rd, Boekelheide K, 2010. Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev 13:51–138.
   PubMed Web of Science ®Google Scholar
• Lai DY. 2011. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol. DOI:10.1002/wnan.162
   PubMedGoogle Scholar
• Laxen DPH. 1977. A specific conductance method for quality control in water analysis. Water Res 11:4.
   Google Scholar
• Lee G, Wang Z, Sehgal R, Chen CH, Kikuno K, Hay B, 2011. Drosophila caspases involved in developmentally regulated programmed cell death of peptidergic neurons during early metamorphosis. J Comp Neurol 519:34–48.
   Google Scholar
• Liu S, Wei L, Hao L, Fang N, Chang MW, Xu R, 2009. Sharper and faster "nano darts" kill more bacteria: a study of antibacterial activity of individually dispersed pristine single-walled carbon nanotube. ACS Nano 3:3891–3902.
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–14270.
   PubMed Web of Science ®Google Scholar
• Mills NL, Donaldson K, Hadoke PW, Boon NA, Macnee W, Cassee FR, 2009. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med 6:36–44.
   PubMedGoogle Scholar
• Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239–253.
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622–627.
   PubMed Web of Science ®Google Scholar
• Oberdorster G. 2007. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1:24.
   Google Scholar
• Oberdorster G, Ferin J, Lehnert BE. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102(Suppl 5):173–179.
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839.
   PubMed Web of Science ®Google Scholar
• OECD. 2010. Preliminary guidance notes on sample preparation and dosimetry for the safety testing of manufactured nanomaterials. [Online] Available at: http://www.oecd.org/officialdocuments/displaydocument/?cote=env/jm/mono(2010)25&doclanguage=en. Accessed on 5 December 2011.
   Google Scholar
• Rallo R, France B, Liu R, Nair S, George S, Damoiseaux R, 2011. Self-organizing map analysis of toxicity-related cell signaling pathways for metal and metal oxide nanoparticles. Environ Sci Technol. DOI: 10.1021/es103606x
   Google Scholar
• Roco MC. 2011. Nanotechnology Research Directions for Societal Needs in 2020. J Nanoparticle Res 13(3):897–919.
   Google Scholar
• Rushton EK, Jiang J, Leonard SS, Eberly S, Castranova V, Biswas P, 2010. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A 73:445–461.
   PubMed Web of Science ®Google Scholar
• Sehgal A, Lalatonne Y, Berret JF, Morvan M. 2005. Precipitation-redispersion of cerium oxide nanoparticles with poly(acrylic acid): toward stable dispersions. Langmuir 21:9359–9364.
   PubMed Web of Science ®Google Scholar
• Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. 2008. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci USA 105:7387–7392.
   PubMed Web of Science ®Google Scholar
• Sotiriou GA, Diaz E, Long MS, Godleski J, Brain J, Pratsinis SE, 2011. A novel platform for pulmonary and cardiovascular toxicological characterization of inhaled engineered nanomaterials. Nanotoxicology. DOI: 10.3109/17435390.2011.604439
   PubMedGoogle Scholar
• Sterling MC JR, Bonner JS, Ernest AN, Page CA, Autenrieth RL. 2005. Application of fractal flocculation and vertical transport model to aquatic sol-sediment systems. Water Res 39:1818–1830.
   PubMedGoogle Scholar
• Sulahian TH, Imrich A, Deloid G, Winkler AR, Kobzik L. 2008. Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry. Respir Res 9:59.
   PubMed Web of Science ®Google Scholar
• Taurozzi J. 2010. Protocol for Preparation of Nanoparticle Dispersions from Powdered Material Using Ultrasonic Disruption. [Online] Available at: http://www.nist.gov/customcf/get_pdf.cfm?pub_id=905633. Accessed on 5 December 2011
   Google Scholar
• Taurozzi JS, Hackley VA, Wiesner MR. 2010. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment - issues and recommendations. Nanotoxicology. DOI: 10.3109/17435390.2010.528846
   PubMedGoogle Scholar
• Tedja R. 2011. Biological impacts of TiO2 on human lung cell lines A549 and H1299: particle size distribution effects. J Nanopart Res 13:13.
   Google Scholar
• Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. 2007. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 95:300–312.
   PubMed Web of Science ®Google Scholar
• Verma A, Stellacci F. 2010. Effect of surface properties on nanoparticle-cell interactions. Small 6:12–21.
   PubMed Web of Science ®Google Scholar
• Wiogo HT, Lim M, Bulmus V, Yun J, Amal R. 2011. Stabilization of magnetic iron oxide nanoparticles in biological media by fetal bovine serum (FBS). Langmuir 27:843–850.
   PubMed Web of Science ®Google Scholar
• Wittmaack K. 2007. In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle exposure. Environ Health Perspect 115:8.
   PubMedGoogle Scholar
• Zook JM, Maccuspie RI, Locascio LE, Halter MD, Elliott JT. 2010. Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity. Nanotoxicology. DOI: 10.3109/17435390.2010.536615
   PubMedGoogle Scholar